Literature DB >> 20428929

Characterization of the ascending colon fluids in ulcerative colitis.

Maria Vertzoni1, Konstantinos Goumas, Erik Söderlind, Bertil Abrahamsson, Jennifer B Dressman, Androniki Poulou, Christos Reppas.   

Abstract

PURPOSE: To characterize the fluid composition in ascending colon of fasted adults with ulcerative colitis in relapse and in remission with a view to predicting variations on dosage form performance in the lower inflamed gut.
METHODS: Twelve patients participated in a two-phase, crossover study. Enrollment to the relapse phase (Phase A) and designation of the remission state for the second colonoscopy (Phase B) were based on Clinical Rachmilewicz Index values. Samples were analyzed for pH and buffer capacity immediately upon collection. After ultracentrifugation, osmolality, surface tension, soluble protein, soluble carbohydrates, and the levels of ten bile acids, seven short-chain fatty acids (SCFAs), three long-chain fatty acids, triglycerides, diglycerides, monoglycerides, phosphatidylcholine, and cholesterol were measured.
RESULTS: Total SCFAs are significantly decreased in relapse, but pH remains unaffected. Regardless of remission/relapse status, pH and isobutyric acid levels are lower than in healthy adults. Buffer capacity, osmolality, and soluble protein are higher than in healthy adults. Treatment with prednisolone increases the volume of intracolonic contents.
CONCLUSION: Variations in fluid composition of the ascending colon with activity and severity of ulcerative colitis may have an impact on the performance of orally administered products that are targeted to release the therapeutic agent in the colon.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20428929     DOI: 10.1007/s11095-010-0158-y

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  25 in total

1.  [Mucus physicochemical properties in children with ulcerative colitis].

Authors:  Krystyna Grzybowska; Krzysztof Gwoździński; Grazyna Zaleśna; Anna Kisiel; Piotr Grzybowski; Izabela Płaneta-Małecka
Journal:  Pol Merkur Lekarski       Date:  2004

2.  Suitability of various noninfinity area under the plasma concentration-time curve (AUC) estimates for use in bioequivalence determinations: relationship to AUC from zero to time infinity (AUC0-INF).

Authors:  M N Martinez; A J Jackson
Journal:  Pharm Res       Date:  1991-04       Impact factor: 4.200

3.  Azathioprine metabolism: pharmacokinetics of 6-mercaptopurine, 6-thiouric acid and 6-thioguanine nucleotides in renal transplant patients.

Authors:  G L Chan; G R Erdmann; S A Gruber; A J Matas; D M Canafax
Journal:  J Clin Pharmacol       Date:  1990-04       Impact factor: 3.126

4.  Characterization of the contents of ascending colon to which drugs are exposed after oral administration to healthy adults.

Authors:  Amalia Diakidou; Maria Vertzoni; Konstantinos Goumas; Erik Söderlind; Bertil Abrahamsson; Jennifer Dressman; Christos Reppas
Journal:  Pharm Res       Date:  2009-07-02       Impact factor: 4.200

5.  Protein-losing enteropathy and massive pulmonary embolism in a patient with giant inflammatory polyposis and quiescent ulcerative colitis.

Authors:  R Anderson; I T Kaariainen; S B Hanauer
Journal:  Am J Med       Date:  1996-09       Impact factor: 4.965

6.  Giant inflammatory polyposis in ulcerative colitis presenting with protein losing enteropathy.

Authors:  R L Bryan; J Newman; J Alexander-Williams
Journal:  J Clin Pathol       Date:  1990-04       Impact factor: 3.411

7.  Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial.

Authors:  D Rachmilewitz
Journal:  BMJ       Date:  1989-01-14

8.  Pharmacokinetics of pantoprazole following single intravenous and oral administration to healthy male subjects.

Authors:  M A Pue; J Laroche; I Meineke; C de Mey
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

9.  Assay of azathioprine, 6-mercaptopurine and a novel thiopurine metabolite in human plasma.

Authors:  J L Maddocks
Journal:  Br J Clin Pharmacol       Date:  1979-09       Impact factor: 4.335

10.  Mucosal inflammation in the terminal ileum of ulcerative colitis patients: endoscopic findings and cytokine profiles.

Authors:  Takayuki Yamamoto; Yasuki Maruyama; Satoru Umegae; Koichi Matsumoto; Abbi R Saniabadi
Journal:  Dig Liver Dis       Date:  2008-02-19       Impact factor: 4.088

View more
  4 in total

1.  Characterization of Contents of Distal Ileum and Cecum to Which Drugs/Drug Products are Exposed During Bioavailability/Bioequivalence Studies in Healthy Adults.

Authors:  Christos Reppas; Eleni Karatza; Constantinos Goumas; Constantinos Markopoulos; Maria Vertzoni
Journal:  Pharm Res       Date:  2015-05-22       Impact factor: 4.200

2.  The role of hyperosmotic stress in inflammation and disease.

Authors:  Chad Brocker; David C Thompson; Vasilis Vasiliou
Journal:  Biomol Concepts       Date:  2012-08

3.  Hypo-osmotic stress induces the epithelial alarmin IL-33 in the colonic barrier of ulcerative colitis.

Authors:  Mona Dixon Gundersen; Kenneth Bowitz Larsen; Kay Martin Johnsen; Rasmus Goll; Jon Florholmen; Guttorm Haraldsen
Journal:  Sci Rep       Date:  2022-07-07       Impact factor: 4.996

4.  Different metabolic features of Bacteroides fragilis growing in the presence of glucose and exopolysaccharides of bifidobacteria.

Authors:  David Rios-Covian; Borja Sánchez; Nuria Salazar; Noelia Martínez; Begoña Redruello; Miguel Gueimonde; Clara G de Los Reyes-Gavilán
Journal:  Front Microbiol       Date:  2015-08-18       Impact factor: 5.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.